Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yingjun Zhang, Weijian Lin, Weiping Jiang & Zhenfa Wang. (2022) MicroRNA-18 facilitates the stemness of gastric cancer by downregulating HMGB3 though targeting Meis2. Bioengineered 13:4, pages 9959-9972.
Read now
Read now
Jiayi Li, Shuxia Fan, Shuang Liu, Guang Yang, Qingsong Jin & Zhen Xiao. (2021) RETRACTED ARTICLE: LncRNA NOP14-AS1 Promotes Tongue Squamous Cell Carcinoma Progression by Targeting MicroRNA-665/HMGB3 Axis. Cancer Management and Research 13, pages 2821-2834.
Read now
Read now
Hao Yu, Liqian Dong, Hongyu Wang, Yang Zhang, Zhuo Wang, Can Wang, Hong Xia & Huizheng Bao. (2021) RETRACTED ARTICLE: LINC00504 Promotes the Malignant Biological Behavior of Breast Cancer Cells by Upregulating HMGB3 via Decoying MicroRNA-876-3p. Cancer Management and Research 13, pages 1803-1815.
Read now
Read now
Junfeng Xi, Yunfeng Xi, Zhibin Zhang, Yanhong Hao, Fei Wu, Burong Bian, Guangjun Hao, Weiwei Li & Shuqun Zhang. (2021) Hsa_circ_0060937 accelerates non-small cell lung cancer progression via modulating miR-195-5p/HMGB3 pathway. Cell Cycle 20:19, pages 2040-2052.
Read now
Read now
Articles from other publishers (39)
Yue Shi, Joseph Adu-Amankwaah, Qizhong Zhao, Xin Li, Qianxue Yu, Aisha Bushi, Jinxiang Yuan & Rubin Tan. (2024) Long non-coding RNAs in drug resistance across the top five cancers: Update on their roles and mechanisms. Heliyon 10:5, pages e27207.
Crossref
Crossref
Yan Wang, Hui Li, Wenbin Chen, Xiaoliang Huang, Renliang Fan, Meijia Xu & Li Zou. (2023) CircRUNX1 drives the malignant phenotypes of lung adenocarcinoma through mediating the miR-5195-3p/HMGB3 network. General Thoracic and Cardiovascular Surgery 72:3, pages 164-175.
Crossref
Crossref
Sirui Li, Conghui Li, Xiaosong Ma, Xuyang Zhang & Liangyu Zhang. (2023) Effect of miR-200b Liposome Nanoparticles on Chemotherapy Resistance in Rats with Breast Cancer Through Induction of Epidermal Growth Factor Receptor/Extracellular Signal-Regulated Kinase Signal Pathway. Journal of Biomedical Nanotechnology 19:12, pages 2078-2084.
Crossref
Crossref
Qianni Yang, Min Li, Yunjiao Hou, Huilin He & Shibo Sun. (2023) High‐mobility group box 1 emerges as a therapeutic target for asthma. Immunity, Inflammation and Disease 11:12.
Crossref
Crossref
Amit Manhas, Dipti Tripathi & Kumaravelu Jagavelu. (2023) Involvement of HIF1α/Reg protein in the regulation of HMGB3 in myocardial infarction. Vascular Pharmacology 152, pages 107197.
Crossref
Crossref
Huaixi Luo, Hao Zhou, Shengyao Jiang, Chuan He, Ke Xu, Jinmei Ding, Jiajia Liu, Chao Qin, Kangchun Chen, Wenchuan Zhou, Liyuan Wang, Wenhao Yang, Wenqi Zhu & He Meng. (2023) Gene Expression Profiling Reveals Potential Players of Sex Determination and Asymmetrical Development in Chicken Embryo Gonads. International Journal of Molecular Sciences 24:19, pages 14597.
Crossref
Crossref
Xueying Zhu, Jian Kang, Yupeng Ma, Qi Wang, Weiwu Li, Juan Su & Xinqi Zhang. (2022) Plasmacytoma variant translocation 1 inhibits miR‐515‐5p function and modulates high mobility group B3 to promote the growth of prostate cancer cells. Andrology 11:4, pages 641-650.
Crossref
Crossref
Yunyi Xu, Miao Xu, Xinglan Li, Xin Weng, Zhengzheng Su, Mengni Zhang, Junya Tan, Hao Zeng, Xun Li, Ling Nie, Jing Gong, Ni Chen, Xueqin Chen & Qiao Zhou. (2022) SOX9 and HMGB3 co‐operatively transactivate NANOG and promote prostate cancer progression. The Prostate 83:5, pages 440-453.
Crossref
Crossref
Amir Abbas Hamidi, Negin Taghehchian, Amir Sadra Zangouei, Iman Akhlaghipour, Amirhosein Maharati, Zahra Basirat & Meysam Moghbeli. (2023) Molecular mechanisms of microRNA-216a during tumor progression. Cancer Cell International 23:1.
Crossref
Crossref
Xiaomei Zhou, Qu Zhang, Gai Liang, Xinjun Liang & Bo Luo. (2022) Overexpression of HMGB3 and its prognostic value in breast cancer. Frontiers in Oncology 12.
Crossref
Crossref
Zhiheng Wu, Yang Huang, Weiwei Yuan, Xiong Wu, Hui Shi, Ming Lu & Aman Xu. (2022) Expression, tumor immune infiltration, and prognostic impact of HMGs in gastric cancer. Frontiers in Oncology 12.
Crossref
Crossref
Fulong Ji, Zhiwei Yao, Chunxiang Liu, Siqi Fu, Bingbing Ren, Yong Liu, Lushun Ma, Jianming Wei & Daqing Sun. (2022) A novel lnc-LAMC2-1:1 SNP promotes colon adenocarcinoma progression by targeting miR-216a-3p/HMGB3. Heliyon 8:12, pages e12342.
Crossref
Crossref
Hong Wu, Haiqin Feng, Xiaoli Miao, Jiancai Ma, Cairu Liu, Lina Zhang & Liping Yang. (2022) Construction and validation of a prognostic model based on 11 lymph node metastasis‐related genes for overall survival in endometrial cancer. Cancer Medicine 11:23, pages 4641-4655.
Crossref
Crossref
Yangying Hu, Deqi Wu, Rong Huang & Zhijie Shi. (2022) HMGB3 Targeted by miR-145-5p Impacts Proliferation, Migration, Invasion, and Apoptosis of Breast Cancer Cells. Computational and Mathematical Methods in Medicine 2022, pages 1-12.
Crossref
Crossref
Xugui Zhao & Jianqing Lin. (2022) Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer. Computational and Mathematical Methods in Medicine 2022, pages 1-21.
Crossref
Crossref
Priyanshu Sharma, Poonam Yadav, Sandhya Sundaram, Ganesh Venkatraman, Amal Kanti Bera & Devarajan Karunagaran. (2022) HMGB3 inhibition by miR-142-3p/sh-RNA modulates autophagy and induces apoptosis via ROS accumulation and mitochondrial dysfunction and reduces the tumorigenic potential of human breast cancer cells. Life Sciences 304, pages 120727.
Crossref
Crossref
Xuefeng Zheng, Xu Wang, Yunduan He & Hong Ge. (2022) Systematic analysis of expression profiles of HMGB family members for prognostic application in non-small cell lung cancer. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Feng Chen, Fang Sun, Xia Liu, Jing Shao & Bei Zhang. (2022) Glaucocalyxin A Inhibits the Malignant Progression of Epithelial Ovarian Cancer by Affecting the MicroRNA-374b-5p/HMGB3/Wnt-β-Catenin Pathway Axis. Frontiers in Oncology 12.
Crossref
Crossref
Hao-dong Tang, Yang Wang, Peng Xie, Si-yuan Tan, Hai-feng Li, Hao Shen, Zheng Zhang, Zheng-qing Lei & Jia-hua Zhou. (2022) The Crosstalk Between Immune Infiltration, Circulating Tumor Cells, and Metastasis in Pancreatic Cancer: Identification of HMGB3 From a Multiple Omics Analysis. Frontiers in Genetics 13.
Crossref
Crossref
Yan Yao, Xinru Kong, Ruijuan Liu, Fei Xu, Gongxi Liu & Changgang Sun. (2022) Development of a Novel Immune-Related Gene Prognostic Index for Breast Cancer. Frontiers in Immunology 13.
Crossref
Crossref
Hanlin Ma, Gonghua Qi, Fang Han, Wei Lu, Jiali Peng, Rongrong Li, Shi Yan, Cunzhong Yuan & Beihua Kong. (2022) HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer. Cell Death & Disease 13:3.
Crossref
Crossref
Bingbing Han, Xiaohong Wang & Xia Yin. (2021) Knockdown of circRAD23B Exerts Antitumor Response in Colorectal Cancer via the Regulation of miR-1205/TRIM44 axis. Digestive Diseases and Sciences 67:2, pages 504-515.
Crossref
Crossref
Dan Sun, Rui Cao, Lu Han, Xiaohui Yu, Huali Wang, Xiuying Wang & Xuelian Chen. (2022) Long Noncoding RNA Brain Cytoplasmic RNA 1 Induces Cisplatin-Resistance of Cervical Cancer Cells by Sponging MicroRNA-330-5p and Upregulating High-Mobility Group Box 3. Gynecologic and Obstetric Investigation 87:3-4, pages 200-210.
Crossref
Crossref
Xiaodan Zhong, Songling Zhang, Yutong Zhang, Zongmiao Jiang, Yanan Li, Jian Chang, Junqi Niu & Ying Shi. (2021) HMGB3 is Associated With an Unfavorable Prognosis of Neuroblastoma and Promotes Tumor Progression by Mediating TPX2. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Tong Lin, Yingzhao Zhang, Zhimei Lin & Lisheng Peng. (2021) Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis. Frontiers in Genetics 12.
Crossref
Crossref
Bing Xiao, Shi-gang Lv, Miao-jing Wu, Xiao-li Shen, Wei Tu, Min-hua Ye & Xin-gen Zhu. (2021) Circ_CLIP2 promotes glioma progression through targeting the miR-195-5p/HMGB3 axis. Journal of Neuro-Oncology 154:2, pages 131-144.
Crossref
Crossref
Zonglin Chen, Lei Pei, Danhua Zhang, Feng Xu, Enxiang Zhou & Xianyu Chen. (2021) HDAC3 increases HMGB3 expression to facilitate the immune escape of breast cancer cells via down-regulating microRNA-130a-3p. The International Journal of Biochemistry & Cell Biology 135, pages 105967.
Crossref
Crossref
Yuhua Chen, Hao Zhou, Zhendong Wang, Zhanghao Huang, Jinjie Wang, Miaosen Zheng, Xuejun Ni & Lei Liu. (2021) Integrated analysis of ceRNA network and tumor-infiltrating immune cells in esophageal cancer. Bioscience Reports 41:5.
Crossref
Crossref
Bin Wen, Ying-ting Wei & Kui Zhao. (2021) The role of high mobility group protein B3 (HMGB3) in tumor proliferation and drug resistance. Molecular and Cellular Biochemistry 476:4, pages 1729-1739.
Crossref
Crossref
Qiang Yu, Yinmou Li, Shijun Peng, Jing Li & Xianxiong Qin. (2021) Exosomal-mediated transfer of OIP5-AS1 enhanced cell chemoresistance to trastuzumab in breast cancer via up-regulating HMGB3 by sponging miR-381-3p. Open Medicine 16:1, pages 512-525.
Crossref
Crossref
Cheng-Xi Sun, Feng Zhu & Lei Qi. (2021) Demethylated miR-216a Regulates High Mobility Group Box 3 Promoting Growth of Esophageal Cancer Cells Through Wnt/β-Catenin Pathway. Frontiers in Oncology 11.
Crossref
Crossref
Jinhui Liu, Jie Mei, Siyue Li, Zhipeng Wu & Yan Zhang. (2020) Establishment of a novel cell cycle-related prognostic signature predicting prognosis in patients with endometrial cancer. Cancer Cell International 20:1.
Crossref
Crossref
Kai Yin & Xianzhi Liu. (2020)
CircMMP1
promotes the progression of glioma through
miR
‐433/
HMGB3
axis in vitro and in vivo
. IUBMB Life 72:11, pages 2508-2524.
Crossref
Crossref
Yunjing Li, Yongfu Ma, Tong Zhang, Changjiang Feng & Yang Liu. (2020) High-mobility group box 3 (HMGB3) silencing inhibits non-small cell lung cancer development through regulating Wnt/β-catenin pathway. Biological Chemistry 401:10, pages 1191-1198.
Crossref
Crossref
Dong Sun, Huan Cao, Liu Yang, Ling Lin, Bin Hou, Weiping Zheng, Zhongyang Shen & Hongli Song. (2020) MiR-200b in heme oxygenase-1-modified bone marrow mesenchymal stem cell-derived exosomes alleviates inflammatory injury of intestinal epithelial cells by targeting high mobility group box 3. Cell Death & Disease 11:6.
Crossref
Crossref
Anirban Mukherjee & Karen M. Vasquez. (2020) Targeting Chromosomal Architectural HMGB Proteins Could Be the Next Frontier in Cancer Therapy. Cancer Research 80:11, pages 2075-2082.
Crossref
Crossref
Shichao Zhuang, Xiaohui Yu, Ming Lu, Yujiao Li, Ning Ding & Yumei Ding. (2020) High mobility group box 3 promotes cervical cancer proliferation by regulating Wnt/β-catenin pathway. Journal of Gynecologic Oncology 31:6.
Crossref
Crossref
Liaoran Niu, Wanli Yang, Lili Duan, Xiaoqian Wang, Yiding Li, Chengchao Xu, Chao Liu, Yujie Zhang, Wei Zhou, Jinqiang Liu, Qingchuan Zhao, Yu Han, Liu Hong & Daiming Fan. (2020) Biological functions and theranostic potential of HMGB family members in human cancers. Therapeutic Advances in Medical Oncology 12, pages 175883592097085.
Crossref
Crossref
Anna Petruczynik, Tomasz Plech, Tomasz Tuzimski, Justyna Misiurek, Barbara Kaproń, Dorota Misiurek, Małgorzata Szultka-Młyńska, Bogusław Buszewski & Monika Waksmundzka-Hajnos. (2019) Determination of Selected Isoquinoline Alkaloids from Mahonia aquifolia; Meconopsis cambrica; Corydalis lutea; Dicentra spectabilis; Fumaria officinalis; Macleaya cordata Extracts by HPLC-DAD and Comparison of Their Cytotoxic Activity. Toxins 11:10, pages 575.
Crossref
Crossref